InvestSMART

ImpediMed Limited (ASX: IPD) - Announcements

- Current share price for IPD : $0.004

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Five Additional Medical Policies Achieved 31 Jul 2023 2:48PM $0.195 $0.004 fallen by 97.95%
$15 Notice received under section 203D of the Corporations Act 31 Jul 2023 8:38AM $0.205 $0.004 fallen by 98.05%
$15 APPENDIX 4C - Quarterly Activities Report 24 Jul 2023 9:09AM $0.200 $0.004 fallen by 98%
$15 First Top 5 National Payor Covering SOZO Testing 19 Jul 2023 9:51AM $0.185 $0.004 fallen by 97.84%
$15 Quarterly Results and Investor Conference Call Notification 17 Jul 2023 8:22AM $0.175 $0.004 fallen by 97.71%
$15 Change of Director's Interest Notice - Mr Donald Williams 6 Jul 2023 8:20AM $0.200 $0.004 fallen by 98%
$15 Change of Director's Interest Notice - Mrs Janet West 6 Jul 2023 8:20AM $0.200 $0.004 fallen by 98%
$15 Change of Director's Interest Notice - Mr Amit Patel 6 Jul 2023 8:20AM $0.200 $0.004 fallen by 98%
$15 Change of Director's Interest Notice - Mr David Anderson 6 Jul 2023 8:20AM $0.200 $0.004 fallen by 98%
$15 Notice under section 708A(5)(e) of the Corporations Act 6 Jul 2023 8:20AM $0.200 $0.004 fallen by 98%
$15 Application for quotation of securities - IPD 6 Jul 2023 8:20AM $0.200 $0.004 fallen by 98%
$15 Initial Director's Interest Notice - Mr Daniel Sharp 3 Jul 2023 6:44PM $0.185 $0.004 fallen by 97.84%
$15 Initial Director's Interest Notice - Mr Michael Van Seiden 3 Jul 2023 6:44PM $0.185 $0.004 fallen by 97.84%
$15 Final Director's Interest Notice - Dr Robert Graham 3 Jul 2023 6:40PM $0.185 $0.004 fallen by 97.84%
$15 Notification of cessation of securities - IPD 3 Jul 2023 8:26AM $0.180 $0.004 fallen by 97.78%
$15 Revised Security Trading Policy 30 Jun 2023 8:18AM $0.185 $0.004 fallen by 97.84%
$15 ImpediMed Achieves Critical Mass in First Key Target State 29 Jun 2023 9:32AM $0.180 $0.004 fallen by 97.78%
$15 ImpediMed Updates Board for Growth in Oncology 28 Jun 2023 8:22AM $0.185 $0.004 fallen by 97.84%
$15 Change of Director's Interest Notice - Mr David Anderson 27 Jun 2023 8:18AM $0.165 $0.004 fallen by 97.58%
$15 Application for quotation of securities - IPD 21 Jun 2023 11:41AM $0.155 $0.004 fallen by 97.42%
$15 SPP Results 21 Jun 2023 11:40AM $0.155 $0.004 fallen by 97.42%
$15 Update - Proposed issue of securities - IPD 21 Jun 2023 11:18AM $0.160 $0.004 fallen by 97.50%
$15 ImpediMed Announces Third Medical Policy Covering SOZO 20 Jun 2023 12:12PM $0.150 $0.004 fallen by 97.33%
$15 Change of Director's Interest Notice - Mrs Janet West 19 Jun 2023 10:10AM $0.150 $0.004 fallen by 97.33%
$15 Notification regarding unquoted securities - IPD 15 Jun 2023 12:24PM $0.155 $0.004 fallen by 97.42%

301 - 325 of 1224 results

Page 13 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.